Pfizer
(NYSE) PFE
Pfizer Financials at a Glance
Market Cap
$137.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$63.32B
Net Income (TTM)
$7.49B
EPS (TTM)
$1.30
P/E Ratio
18.53
Dividend
$1.72
Beta (Volatility)
0.41 (Low)
Dividend
$1.72
Beta (Volatility)
0.41 (Low)
Price
$24.22
Volume
27,523,178.204
Open
$24.35
Price
$24.22
Volume
27,523,178.204
Open
$24.35
Previous Close
$24.17
Daily Range
$24.10 - $24.41
52-Week Range
$23.11 - $28.75
Estimated Earnings Date
Aug 4, 2026
Dividend
$1.72
Beta (Volatility)
0.41 (Low)
Price
$24.22
Volume
27,523,178.204
Open
$24.35
Previous Close
$24.17
Daily Range
$24.10 - $24.41
52-Week Range
$23.11 - $28.75
Estimated Earnings Date
Aug 4, 2026
PFE News
PFE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pfizer
Industry
Pharmaceuticals
Sector
Health CareEmployees
75,000
CEO
Albert Bourla, PhD, DVM
Website
www.pfizer.comHeadquarters
New York City, NY 10001-2192, US
PFE Financials
Key Financial Metrics (TTM)
Gross Margin
69.35%
Operating Margin
23.45%
Net Income Margin
11.83%
Return on Equity
8.37%
Return on Capital
10.03%
Return on Assets
3.61%
Earnings Yield
5.40%
Dividend Yield
7.12%
Payout Ratio
1.31%
Stock Overview
Market Cap
$137.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
5.70B
Volume
27.52M
Avg. Volume
40.25M
Financials (TTM)
Gross Profit
$43.91B
Operating Income
$14.85B
EBITDA
$16.75B
Operating Cash Flow
$11.99B
Capital Expenditure
-$2.50B
Free Cash Flow
$9.48B
Cash & ST Invst.
$13.08B
Total Debt
$64.46B
Pfizer Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$14.45B
+5.4%
Gross Profit
$9.72B
-1.1%
Gross Margin
67.26%
N/A
Market Cap
$137.76BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.70M
N/A
Employees
81,000
N/A
Net Income
$2.69B
-9.4%
EBITDA
$5.02B
-0.7%
Quarterly Fundamentals
Total Cash
$13.08B
-24.5%
Total Debt
$64.46B
+5.2%
Accounts Receivable
$12.59B
-14.6%
Inventory
$10.67B
-1.7%
Long Term Debt
$60.57B
+6.6%
Short Term Debt
$3.89B
-13.0%
Return on Assets
3.61%
N/A
Return on Invested Capital
8.57%
N/A
Free Cash Flow
$2.18B
+23.0%
Operating Cash Flow
$2.62B
+12.0%